What is the 13F Pro Quality Score for INNV?

13F Pro ranks InnovAge Holding Corp. (INNV) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View INNV's current score at https://13fpro.ai/company/INNV (free sign-up required for the full ranking).

Which hedge funds own the most INNV stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of INNV include T. Rowe Price Investment Management,, FEDERATED HERMES,, BlackRock,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/INNV as soon as new 13F filings post.

Where does 13F Pro source INNV data?

All InnovAge Holding Corp. fundamentals and ownership data come directly from SEC EDGAR. InnovAge Holding Corp. files with the SEC under CIK 1834376. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is INNV in?

InnovAge Holding Corp. (INNV) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is INNV research updated on 13F Pro?

INNV's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

InnovAge Holding Corp.(INNV)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1834376 INNV stock profile & AI dashboard →

13F Pro Quality Score

55.0/100

Rank #1,281 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

68.8/100

Profitability

43.2/100

Balance Sheet

32.8/100

Earnings Quality

97.4/100

Free Cash Flow

42.7/100

Institutional Flow

45.6/100

Revenue Scale

49.6/100

Dilution Risk

66.8/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why INNV Scores 55/100

exact factor attribution · 2026-09-11

INNV's composite is driven by earnings quality and revenue growth, held back by capital efficiency and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+4.7 pts

97th pct

Revenue growth

+3.8 pts

69th pct

Shareholder dilution

+0.8 pts

67th pct

Scale

-0.1 pts

50th pct

Earnings growth

-0.2 pts

46th pct

Institutional flow

-0.2 pts

46th pct

Profitability

-1.0 pts

43th pct

Free cash flow

-1.1 pts

43th pct

Capital efficiency

-1.7 pts

33th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

INNV Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for InnovAge Holding Corp. (INNV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INNV at 55.0/100 on a 32-signal composite quality model, placing it at rank #1,281 of 2,962 stocks — the top half of the AI-ranked universe. INNV scores in the top quartile across earnings quality (97.4). Areas of concern include balance sheet strength (32.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), InnovAge Holding Corp. reports quarterly revenue of $262.0M, net income of $8.3M, an operating margin of 3.9%. Top institutional holders of INNV by reported 13-F value include T. Rowe Price Investment Management, FEDERATED HERMES, BlackRock, based on the most recent SEC filings. INNV trades on the Nasdaq exchange and files with the SEC under CIK 1834376. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INNV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InnovAge Holding Corp. directly from SEC EDGAR. InnovAge Holding Corp.'s 13F Pro composite quality score has ranged between 33 and 56 since 2024, currently 55.0 — an improving long-term trajectory across 55 quarterly and live scoring snapshots.

✦

Fun facts about InnovAge Holding Corp.

Quirks, history, and lore behind INNV — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · small-cap · listed on Nasdaq · headquartered in Colorado.
2
The Numbers
Annual revenue in the low hundreds of millions of dollars, serving a population that is both elderly and low-income — a dual-eligibility sweet spot that drives its entire business model.
3
The History
Founded in the early 2000s, it went public around 2021 and built its model around a federal program designed to keep frail seniors out of nursing homes.
4
The Secret
It operates under the PACE model — Program of All-inclusive Care for the Elderly — where it receives capitated payments to manage every aspect of a participant's medical and social needs.
5
The Lore
The company faced federal and state regulatory scrutiny in the early 2020s over care quality concerns, sending its stock on a dramatic slide shortly after its IPO honeymoon ended.
6
The Giveaway
It's the largest pure-play PACE provider in the U.S., keeping senior participants living independently by wrapping medical, social, and day-center care into one all-inclusive program — ticker: INNV.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$262.0M

Net Income

Q2 2026

$8.3M

Free Cash Flow

Q2 2026

$17.0M

Operating Margin

Q2 2026

3.9%

ROIC

Q2 2026

14.1%

D/E Ratio

Q2 2026

0.22

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+15.9% YoY

$989.7MFY 2026

FY23 $688.1MFY24 $763.9MFY25 $853.7MFY26 $989.7M

Net Income

+91.6% YoY

$-2.5MFY 2026

FY23 $-40.7MFY24 $-21.3MFY25 $-30.3MFY26 $-2.5M

Operating Income

+108.8% YoY

$2.6MFY 2026

FY23 $-49.4MFY24 $-23.2MFY25 $-29.8MFY26 $2.6M

EPS (Diluted)

+90.9% YoY

$-0.02FY 2026

FY23 $-0.30FY24 $-0.16FY25 $-0.22FY26 $-0.02

Total Assets

+5.8% YoY

$557.4MFY 2026

FY23 $567.4MFY24 $547.7MFY25 $526.9MFY26 $557.4M

Total Debt

-17.5% YoY

$51.3MFY 2026

FY23 $73.6MFY24 $69.8MFY25 $62.3MFY26 $51.3M

Op. Cash Flow

+96.9% YoY

$64.7MFY 2026

FY23 $20.2MFY24 $-36.9MFY25 $32.9MFY26 $64.7M

Free Cash Flow

+89.5% YoY

$50.4MFY 2026

FY23 $-3.1MFY24 $-44.8MFY25 $26.6MFY26 $50.4M

Metric	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$989.7M +15.9%	$853.7M +11.8%	$763.9M +11.0%	$688.1M -1.5%	$698.6M +9.5%	$637.8M
Net Income	$-2.5M +91.6%	$-30.3M -42.1%	$-21.3M +47.5%	$-40.7M -523.7%	$-6.5M +85.2%	$-44.0M
Operating Income	$2.6M +108.8%	$-29.8M -28.4%	$-23.2M +53.1%	$-49.4M -1021.1%	$-4.4M +64.3%	$-12.3M
EPS (Diluted)	$-0.02 +90.9%	$-0.22 -37.5%	$-0.16 +46.7%	$-0.30 -500.0%	$-0.05 +86.1%	$-0.36
Total Assets	$557.4M +5.8%	$526.9M -3.8%	$547.7M -3.5%	$567.4M +2.1%	$555.6M +4.5%	$531.8M
Total Debt	$51.3M -17.5%	$62.3M -10.8%	$69.8M -5.2%	$73.6M -4.9%	$77.4M -4.7%	$81.2M
Operating Cash Flow	$64.7M +96.9%	$32.9M +189.1%	$-36.9M -282.3%	$20.2M -25.9%	$27.3M +461.7%	$-7.5M
Free Cash Flow	$50.4M +89.5%	$26.6M +159.4%	$-44.8M -1337.2%	$-3.1M +71.5%	$-10.9M +56.4%	$-25.1M

Get alerted when INNV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for InnovAge Holding Corp. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of INNV

T. Rowe Price Investment Management, Inc.
$72.6M6,124,069 sh
FEDERATED HERMES, INC.
$22.6M1,903,713 sh
BlackRock, Inc.
$17.7M1,489,609 sh
VANGUARD CAPITAL MANAGEMENT LLC
$11.1M935,264 sh
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$7.9M668,742 sh
ALGERT GLOBAL LLC
$7.5M630,520 sh
GEODE CAPITAL MANAGEMENT, LLC
$7.1M602,127 sh
STATE STREET CORP
$5.5M461,656 sh
DIMENSIONAL FUND ADVISORS LP
$5.2M439,962 sh
ACADIAN ASSET MANAGEMENT LLC
$4.6M390,850 sh

Fund	Value	Shares
T. Rowe Price Investment Management, Inc.	$72.6M	6,124,069
FEDERATED HERMES, INC.	$22.6M	1,903,713
BlackRock, Inc.	$17.7M	1,489,609
VANGUARD CAPITAL MANAGEMENT LLC	$11.1M	935,264
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$7.9M	668,742
ALGERT GLOBAL LLC	$7.5M	630,520
GEODE CAPITAL MANAGEMENT, LLC	$7.1M	602,127
STATE STREET CORP	$5.5M	461,656
DIMENSIONAL FUND ADVISORS LP	$5.2M	439,962
ACADIAN ASSET MANAGEMENT LLC	$4.6M	390,850

Companies Similar to INNV

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

INGN

Inogen Inc

AI score

Similar quality profile · 1 shared holders

Kent Lake PR LLC

EHAB

Enhabit, Inc.

AI score

Similar quality profile · 1 shared holders

Kent Lake PR LLC

TFX

TELEFLEX INC

AI score

Similar quality profile · 3 shared holders

T. Rowe Price Investment Management, Inc.Kent Lake PR LLC MIRABELLA FINANCIAL SERVICES LLP

USNA

USANA HEALTH SCIENCES INC

AI score

Similar quality profile · 2 shared holders

Verdad Advisers, LP OCCUDO QUANTITATIVE STRATEGIES LP

ECVT

Ecovyst Inc.

AI score

Similar quality profile · 2 shared holders

OCCUDO QUANTITATIVE STRATEGIES LP Integrated Quantitative Investments LLC

NPCE

NeuroPace Inc

AI score

Similar quality profile · 2 shared holders

Kent Lake PR LLC GWN SECURITIES INC.

SGRY

Surgery Partners, Inc.

AI score

Similar quality profile · 3 shared holders

T. Rowe Price Investment Management, Inc.ZACKS INVESTMENT MANAGEMENT MIRABELLA FINANCIAL SERVICES LLP

VMD

VIEMED HEALTHCARE, INC.

AI score

Similar quality profile · 4 shared holders

Kent Lake PR LLC Verdad Advisers, LP Integrated Quantitative Investments LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put INNV on your watchlist

Track score changes the day InnovAge Holding Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is INNV a good stock to buy?

13F Pro's AI-powered analysis of InnovAge Holding Corp. (INNV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INNV are available on the INNV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. INNV is classified as a small company.

Which hedge funds own INNV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INNV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InnovAge Holding Corp.'s investment landscape.